All
Proteon Pharmaceuticals and Skretting to co-develop new phage-based solutions for aquaculture
Proteon Pharmaceuticals announced a strategic partnership with Skretting aimed at providing functional solutions to tackle health challenges in the aquaculture industry. The...
Isabelle de Cremoux, CEO and Managing Partner, Seventure Partners explains Why microbiota samples should be collected in all clinical trials?
In recent years, the understanding of how the microbiome and human health are linked has expanded considerably. We believe the rise in this understanding and the growing...
The century of the microbiome: an exciting time for human health
While the pandemic might have caused some disruption, microbiome research hasn’t slowed down at all, notes Isabelle de Cremoux, CEO and Managing Partner, Seventure...
Tapping the full potential of wealth management for everyone: wealthpilot receives investment for expansion into new market segments
Wealthpilot taps the full potential of wealth management for end customers, wealth managers and banks – with this goal in mind, wealthpilot has created the financial home of...
‘Significant interest’: Venture capital major Seventure Partners extends €200m+ microbiome fund
European life sciences investment firm Seventure Partners has extended the final close of its second microbiome innovation fund and increased focus on advances in the skin...
Vedanta Biosciences Announces $25Million Investment from Pfizer Inc.
A leading clinical-stage company developing a new category of therapies for immune-mediated diseases basedon rationally defined consortia of human microbiome-derived bacteria,...
Health for Life Capital Fund, managed by Seventure Partners, increases focus on skin microbiome in its portfolio
Seventure Partners, one of Europe’s leaders in financing innovation and a world leader in life science microbiome investment, has increased focus on skin microbiome...
Pioneering a full-ecosystem microbiota approach to improve survival outcomes in life-threatening diseases by Hervé Affagard (Maat Pharma) published on europeanpharmaceuticalreview.com
Pioneering a full-ecosystem microbiota approach to improve survival outcomes in life-threatening diseases by Hervé Affagard (Maat Pharma) published on...